Sharon Walsh

14.5k total citations · 7 hit papers
191 papers, 9.5k citations indexed

About

Sharon Walsh is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sharon Walsh has authored 191 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Public Health, Environmental and Occupational Health, 49 papers in Epidemiology and 43 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sharon Walsh's work include Opioid Use Disorder Treatment (118 papers), Substance Abuse Treatment and Outcomes (41 papers) and Pain Management and Opioid Use (34 papers). Sharon Walsh is often cited by papers focused on Opioid Use Disorder Treatment (118 papers), Substance Abuse Treatment and Outcomes (41 papers) and Pain Management and Opioid Use (34 papers). Sharon Walsh collaborates with scholars based in United States, United Kingdom and Canada. Sharon Walsh's co-authors include George E. Bigelow, Michelle R. Lofwall, Maxine L. Stitzer, Eric C. Strain, Kenzie L. Preston, Paul A. Nuzzo, Shanna Babalonis, George E. Bigelow, Peter Tugwell and Alejandro R. Jadad and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Sharon Walsh

180 papers receiving 9.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists

1995 1.0k citations Sharon Walsh et al. profile →
Clinical pharmacology of buprenorphine: Ceiling effects at high doses

1994 618 citations Sharon Walsh, Kenzie L. Preston et al. profile →
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence

2000 507 citations Eric C. Strain, Sharon Walsh et al. profile →
Opioid use disorder

2020 354 citations Sharon Walsh et al. profile →
Signal of increased opioid overdose during COVID-19 from emergency medical services data

2020 316 citations Svetla Slavova, Sharon Walsh et al. Drug and Alcohol Dependence profile →
Gabapentin misuse, abuse and diversion: a systematic review

2016 263 citations Rachel Vickers‐Smith, Sharon Walsh et al. profile →
Cannabidiol: pharmacology and therapeutic targets

2020 193 citations Shanna Babalonis, Sharon Walsh et al. Psychopharmacology profile →

Peers

Countries citing papers authored by Sharon Walsh

Since Specialization

Citations

This map shows the geographic impact of Sharon Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Walsh more than expected).

Fields of papers citing papers by Sharon Walsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Walsh. The network helps show where Sharon Walsh may publish in the future.

Co-authorship network of co-authors of Sharon Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Walsh. A scholar is included among the top collaborators of Sharon Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Walsh. Sharon Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The costs of peer recovery support services provided through two models within a recovery community center 2025 ·Journal of Substance Use and Addiction Treatment ·(unknown), (unknown), (unknown), Amanda Fallin‐Bennett, (unknown), (unknown), (unknown), (unknown), Sharon Walsh, Kathryn E. McCollister	0
2	Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial 2025 ·Journal of Addiction Medicine ·Michelle R. Lofwall, Edward V. Nunes, Sharon Walsh, Genie L. Bailey, Michael Frost, (unknown), (unknown), (unknown), Peter Almgren, Stefan Peterson, Fredrik Tiberg	1
3	Association of fentanyl test strip results and change in drug use behaviors: A multi-state, community-based observational study 2025 ·International Journal of Drug Policy ·Kitty H. Gelberg, (unknown), Denise C. Babineau, Rachel Vickers‐Smith, Laura Fanucchi, Janet E. Childerhose, Megan E. Hall, (unknown), Jennifer Villani, (unknown), (unknown), Katherine R. Marks, K. Lancaster, Louisa Gilbert, (unknown), (unknown), (unknown), Emmanuel Oga, Redonna K. Chandler, Sharon Walsh	1
4	Medication disposal within reach: Assessing implementation of permanent disposal receptacles in community pharmacies 2024 ·Drug and Alcohol Dependence ·(unknown), (unknown), (unknown), Douglas R. Oyler, (unknown), Hannah K. Knudsen, Sharon Walsh, Patricia R. Freeman	0
5	Policies Relevant to the Healing Communities Study Kentucky Site Implementation 2024 ·Drug and Alcohol Dependence ·(unknown), Jeffery Talbert, Christopher Cook, Daniel R. Harris, (unknown), (unknown), (unknown), Patricia R. Freeman, Katherine R. Marks, Laura Fanucchi, Sharon Walsh, Michelle R. Lofwall	1
6	Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder 2024 ·Neuropsychopharmacology ·Sharon Walsh, Sandra D. Comer, (unknown), Céline Sarr, (unknown), (unknown), Peter Hjelmström, Fredrik Tiberg	3
7	Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality 2024 ·Journal of Addiction Medicine ·Feitong Lei, Michelle R. Lofwall, Jana McAninch, (unknown), Emily Slade, Patricia R. Freeman, Daniela C. Moga, Nabarun Dasgupta, Sharon Walsh, (unknown), Svetla Slavova	5
8	Equity of overdose education and naloxone distribution provided in the Kentucky HEALing Communities Study 2024 ·SHILAP Revista de lepidopterología ·Douglas R. Oyler, Hannah K. Knudsen, Carrie B. Oser, Sharon Walsh, (unknown), (unknown), Philip M. Westgate, Patricia R. Freeman	7
9	Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl 2023 ·JAMA Network Open ·Gail D’Onofrio, Kathryn Hawk, Jeanmarie Perrone, Sharon Walsh, Michelle R. Lofwall, David A. Fiellin, Andrew A. Herring	38
10	Broadband internet subscription rates and opioid prescribing via telemedicine during the COVID‐19 pandemic 2022 ·The Journal of Rural Health ·Douglas R. Oyler, Svetla Slavova, Patricia R. Freeman, (unknown), Jeffery Talbert, Sharon Walsh, Philip M. Westgate	5
11	The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States 2022 ·Drug and Alcohol Dependence ·Hannah K. Knudsen, (unknown), Sharon Walsh	10
12	1635. Do Persons With Opioid Use Disorder and Injection-Related Infections Really Need Prolonged Hospitalizations to Complete Intravenous Antibiotic Therapy? 2018 ·Open Forum Infectious Diseases ·Laura Fanucchi, Sharon Walsh, Alice Thornton, Paul A. Nuzzo, Michelle R. Lofwall	2
13	Perceptions and practices addressing diversion among US buprenorphine prescribers 2018 ·Drug and Alcohol Dependence ·Lewei Lin, Michelle R. Lofwall, Sharon Walsh, Adam J. Gordon, Hannah K. Knudsen	34
14	Effects of Short-Term Oxycodone Maintenance on Experimental Pain Responses in Physically Dependent Opioid Abusers 2017 ·Journal of Pain ·Marion A. Coe, Paul A. Nuzzo, Michelle R. Lofwall, Sharon Walsh	4
15	Abuse liability and reinforcing efficacy of oral tramadol in humans 2012 ·Drug and Alcohol Dependence ·Shanna Babalonis, Michelle R. Lofwall, Paul A. Nuzzo, (unknown), Sharon Walsh	106
16	Modest opioid withdrawal suppression efficacy of oral tramadol in humans 2007 ·Psychopharmacology ·Michelle R. Lofwall, Sharon Walsh, George E. Bigelow, Eric C. Strain	38
17	Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone 2007 ·Drug and Alcohol Dependence ·(unknown), Sharon Walsh, George E. Bigelow, Eric C. Strain	77
18	Effects of buprenorphine/naloxone in opioid-dependent humans 2001 ·Psychopharmacology ·Kenneth B. Stoller, George E. Bigelow, Sharon Walsh, Eric C. Strain	144
19	Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Kory Schuh, Sharon Walsh, George E. Bigelow, Kenzie L. Preston, Maxine L. Stitzer	37
20	Clinical pharmacology of buprenorphine 1995 ·Maxine L. Stitzer, Sharon Walsh, Eric C. Strain, Kory Schuh, G. E. Bigelow, Walter Ling, C. James Klett, Margaret A. Compton	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact